<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Physiology of dyspnea</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Physiology of dyspnea</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Physiology of dyspnea</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard M Schwartzstein, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Meredith C McCormack, MD, MHS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Dieffenbach, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 09, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Breathing discomfort is one of the most common and distressing symptoms experienced by patients. While there are no symptom-specific data about the prevalence of this problem in ambulatory patients, the epidemiology of cardiac and pulmonary diseases indicates that the magnitude of the problem is large. Cardiac disease is the leading cause of death in the United States, and individuals with angina or myocardial infarction often experience breathlessness as the major (and sometimes sole) indicator that they are ill [<a href="#rid1">1</a>]. In addition, asthma and chronic obstructive pulmonary disease (COPD) afflict approximately 34 million people in the United States, many of whom are unaware of their diagnosis, and they typically seek help from clinicians for relief of breathlessness [<a href="#rid2">2,3</a>]. Data from patients admitted to the hospital suggest that 16 percent of patients suffer from dyspnea within 24 hours of admission [<a href="#rid4">4</a>] and that the presence of dyspnea during the hospitalization is associated with a higher mortality [<a href="#rid5">5</a>].</p><p>The pathophysiology of dyspnea will be reviewed here. Factors affecting the control of ventilation and disorders of ventilation, and an approach to a patient with dyspnea, are presented separately. (See  <a class="medical medical_review" href="/d/html/5112.html" rel="external">"Control of ventilation"</a> and  <a class="medical medical_review" href="/d/html/5113.html" rel="external">"Disorders of ventilatory control"</a> and  <a class="medical medical_review" href="/d/html/1436.html" rel="external">"Approach to the patient with dyspnea"</a>.)</p><p class="headingAnchor" id="H608091884"><span class="h1">DESCRIPTIONS OF DYSPNEA</span><span class="headingEndMark"> — </span>Investigations of the descriptors used by patients, or the "language" of dyspnea, suggest that this symptom represents a number of qualitatively distinct sensations, and that the words utilized by patients to describe their breathing discomfort may provide insights into the underlying pathophysiology of the disease [<a href="#rid6">6-9</a>]. Furthermore, there is a growing recognition that one must distinguish between a "sensation" (the neural activation resulting from the stimulation of a receptor) and a "perception" (the reaction of the individual to that sensation) [<a href="#rid10">10-12</a>] and that healthcare providers are relatively poor at estimating the intensity of dyspnea by observing patients [<a href="#rid13">13,14</a>]. In addition, for a given intensity of a breathing sensation, the unpleasantness of the sensation may vary with the stimulus [<a href="#rid15">15</a>].</p><p>A consensus statement of the American Thoracic Society (ATS) has defined dyspnea as "a term used to characterize a subjective experience of breathing discomfort that comprises qualitatively distinct sensations that vary in intensity. The experience derives from interactions among multiple physiological, psychological, social, and environmental factors, and may induce secondary physiological and behavioral responses" [<a href="#rid10">10</a>].</p><p>The respiratory system is designed to maintain homeostasis with respect to gas exchange (adequate oxygenation) and the acid-base status of the organism (adjust arterial tension of carbon dioxide [PaCO<sub>2</sub>] to maintain normal pH). Derangements in oxygenation as well as acidemia lead to breathing discomfort. However, the development of dyspnea is a complex phenomenon which, in many patients, is the result of stimulation of a variety of mechanoreceptors throughout the upper airway, lungs, and chest wall, and which must also account for the sensations that arise when there is a mechanical load on the system (eg, increased airway resistance or decreased lung and/or chest wall compliance). Failure to achieve the expected flow of air into the lungs and/or displacement of the lungs and chest wall for a given output from respiratory centers (ie, the drive to breathe) may intensify dyspnea associated with many pathologic abnormalities. The origins of dyspnea associated with the inadequate delivery of oxygen to, or utilization by, peripheral muscles are less well understood, but are felt to be related to stimulation of metaboreceptors and deserve consideration as well.</p><p class="headingAnchor" id="H2"><span class="h1">INCREASED OUTPUT FROM THE RESPIRATORY CENTERS</span><span class="headingEndMark"> — </span>Most conditions that are associated with respiratory discomfort are characterized by increases in ventilation in response to derangements in ventilation-perfusion matching, increases in dead space, the presence of metabolic acidosis, or stimulation of pulmonary or chest wall receptors. For many years it was believed that this increase in stimulation of the respiratory centers and the resultant augmentation of activity of the ventilatory muscles was responsible for dyspnea. However, subsequent data suggest that the intensity of respiratory discomfort for a given level of ventilation may vary considerably depending upon the nature of the stimulus giving rise to the hyperpnea, and that stimulation of chemoreceptors can produce dyspnea even in the absence of activation of the respiratory muscles (<a class="graphic graphic_figure graphicRef69322" href="/d/graphic/69322.html" rel="external">figure 1</a>).</p><p class="headingAnchor" id="H3"><span class="h2">Chemoreceptors</span><span class="headingEndMark"> — </span>The peripheral chemoreceptors, located in the carotid bodies and aortic arch, sense changes in the partial pressure of oxygen in arterial blood and are also stimulated by acidosis and hypercapnia. The central chemoreceptors, located in the medulla, respond to changes in pH and arterial tension of carbon dioxide (PaCO<sub>2</sub>). Acute hypercapnia is generally a much stronger stimulus for respiratory discomfort than is acute hypoxemia. (See  <a class="medical medical_review" href="/d/html/5112.html" rel="external">"Control of ventilation"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Acute hypercapnia</span><span class="headingEndMark"> — </span>While acute hypercapnia typically leads to brisk increases in ventilation, dyspnea can result from hypercapnia among ventilator-dependent C1-2 quadriplegics who lack functioning respiratory muscles and in normal subjects paralyzed with neuromuscular blocking agents [<a href="#rid16">16,17</a>]. In a different experimental model, normal subjects maintaining a targeted ventilation experienced greater dyspnea when made hypercapnic than when eucapnic conditions were maintained [<a href="#rid18">18</a>]. These results are consistent with the notion that there are direct projections from the brainstem chemoreceptors to the sensory cortex, ie, there is a "corollary discharge" or neural discharge to the sensory cortex that is generated simultaneously with and in proportion to the brainstem neural output to the respiratory muscles [<a href="#rid19">19</a>]. </p><p>Evidence that one can experience some form of dyspnea in the absence of functioning central chemoreceptors is provided by studies of individuals with congenital central hypoventilation syndrome [<a href="#rid20">20</a>]. Many of these individuals breathe relatively normally when awake but have cessation of breathing and respiratory arrest when they are asleep and must be maintained on mechanical ventilation while sleeping. Although they do not increase ventilation or become dyspneic with acute hypercapnia, exercise hyperpnea and breathing discomfort with exercise persist. (See <a class="local">'Impaired oxygen delivery or utilization'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Acute hypoxemia</span><span class="headingEndMark"> — </span>Acute hypoxemia is also associated with increases in ventilation and respiratory discomfort. While the data supporting a direct role for hypoxic stimulation of chemoreceptors in the production of dyspnea are less clear than with hypercapnia, it seems likely that hypoxemia can produce breathing discomfort independently of changes in ventilation. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>Subjects exercising under hypoxic conditions experience more dyspnea than when performing the same activity while breathing room air, and less dyspnea when breathing 100 percent oxygen [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Similar results have been obtained in patients with chronic obstructive pulmonary disease (COPD) who exercise with varying degrees of hypoxia [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Progressive hypoxemia in normal subjects is associated with greater breathing discomfort than comparable degrees of ventilation resulting from exercise [<a href="#rid23">23</a>], demonstrating an effect of hypoxemia on dyspnea that is independent of minute ventilation.</p><p></p><p>Nonetheless, hypoxemia alone or in the setting of minimal underlying cardiopulmonary abnormalities is a relatively weak stimulus for dyspnea, particularly if compensatory hyperventilation with resulting hypocapnia ensues; misunderstanding of this phenomenon may explain the notion of the "happy hypoxemic" patient with mild coronavirus disease 2019 (COVID-19) [<a href="#rid24">24</a>]. Consequently, it is common that patients with hypoxemia and severe lung disease may experience little improvement of dyspnea despite administration of supplemental oxygen.</p><p class="headingAnchor" id="H6"><span class="h1">STIMULATION OF MECHANORECEPTORS</span><span class="headingEndMark"> — </span>Throughout the airways, lungs, and chest wall are a variety of receptors that assist the body in monitoring changes in pressure, flow, and volume in the respiratory system. Information from these receptors is integrated by the central nervous system in a manner that modulates the intensity of dyspnea. However, in some cases, most notably the "chest tightness" associated with bronchoconstriction, the receptors may be the primary source of the sensation [<a href="#rid25">25,26</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Upper airway receptors</span><span class="headingEndMark"> — </span>Stimulation of receptors in the face and upper airway, which are largely innervated by the trigeminal nerve, can <strong>reduce</strong> the intensity of dyspnea. As examples, cold air directed against the face increases breathholding time and reduces the respiratory discomfort associated with breathing against an inspiratory load [<a href="#rid27">27,28</a>]. Presumed stimulation of flow or temperature receptors by the inhalation of cold air reduces exertional dyspnea and ventilation in patients with chronic obstructive pulmonary disease (COPD), while reductions in upper airway receptor stimulation achieved with topical <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> or by the inhalation of warm, humidified air worsen respiratory discomfort in normal subjects [<a href="#rid29">29,30</a>]. High-flow nasal oxygen has been shown to reduce dyspnea to a greater degree than standard supplemental oxygen therapy [<a href="#rid31">31</a>], presumably because of greater stimulation of nasal receptors. </p><p class="headingAnchor" id="H8"><span class="h2">Pulmonary receptors</span><span class="headingEndMark"> — </span>The lung is populated by three major categories of receptors that transmit information relevant to respiratory sensation to the central nervous system via the vagus nerve:</p><p class="bulletIndent1"><span class="glyph">●</span>Slowly adapting receptors, also known as pulmonary stretch receptors, are activated by an increase in tension in the walls of airways, thereby providing information about increases in lung volume.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapidly adapting receptors or irritant receptors are stimulated by rapid changes in lung volume, direct mechanical stimuli, or inhalation of irritant particulate matter or chemicals such as histamine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>C-fibers are unmyelinated afferent nerve fibers that originate in J-receptors located in small airways and near alveolar capillaries; they are stimulated by mechanical and chemical factors.</p><p></p><p>The configuration of these receptors is such that limitations of the movement of the respiratory system exacerbate dyspnea in a variety of experimental conditions, including breathholding and acute hypercapnia [<a href="#rid32">32-34</a>]. Restriction of tidal volume associated with hyperinflation may also contribute to the discomfort experienced by patients with emphysema [<a href="#rid35">35</a>] and by mechanically ventilated patients receiving low tidal volumes [<a href="#rid36">36</a>].</p><p>Inhaled <a class="drug drug_general" data-topicid="8482" href="/d/drug information/8482.html" rel="external">furosemide</a> is hypothesized to stimulate pulmonary stretch receptors. It has been shown to reduce dyspnea in healthy subjects in whom dyspnea was induced using a large resistive load plus hypercapnia [<a href="#rid37">37</a>]. Similarly, dyspnea associated with acute hypercapnia and a restricted tidal volume, as well as the breathlessness associated with exercise, is ameliorated by inhaled furosemide [<a href="#rid38">38,39</a>]. More controlled administration of inhaled furosemide with a similar model of producing dyspnea with hypercapnia and restricted tidal volume, however, resulted in a highly variable response among individuals and group differences compared with placebo are not significant [<a href="#rid40">40,41</a>].</p><p>Stimulation of pulmonary receptors may provoke the dyspnea of asthma. While the work of breathing is increased in patients with acute bronchoconstriction due to changes in airways resistance and hyperinflation, the intensity of dyspnea is greater with acute bronchoconstriction than with external resistive loads at comparable degrees of airway resistance [<a href="#rid25">25,26</a>], and the quality of the discomfort is different [<a href="#rid6">6,7,25,26,42</a>]. Breathing against an external load leads to a sensation of increased "effort" or "work" of breathing, while acute bronchospasm is associated with a sensation of "chest tightness or constriction." Furthermore, the inhalation of <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> appears to blunt the dyspnea of bronchoconstriction, consistent with the hypothesis that stimulation of pulmonary receptors is contributing to the breathing discomfort [<a href="#rid25">25</a>]. Activation of pulmonary receptors may also play a role in the dyspnea of acute pulmonary embolism [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H9"><span class="h2">Chest wall receptors</span><span class="headingEndMark"> — </span>Information from muscle spindles and tendon organs within the chest wall is also important to the perception of dyspnea. Muscle spindles function as length or stretch receptors, while tendon organs monitor force generation. As noted above, constrained chest wall movement exacerbates dyspnea associated with acute hypercapnia, although the relative roles of pulmonary and chest wall receptors are difficult to ascertain [<a href="#rid33">33,34</a>].</p><p>Investigators have studied the importance of chest wall receptors on dyspnea by applying mechanical vibrators to the intercostal space, resulting in stimulation of muscle spindles. In-phase vibration, ie, vibration applied to the inspiratory muscles during inspiration, reduces dyspnea in normal subjects made breathless with hypercapnia and an external resistive load [<a href="#rid44">44</a>]. Similar results were obtained in patients with COPD at rest [<a href="#rid45">45</a>] and while breathing carbon dioxide [<a href="#rid46">46</a>], although vibration appeared to have little effect at higher degrees of discomfort associated with exercise on a cycle ergometer [<a href="#rid46">46</a>]. Timing of the stimulation also appears to be important because out-of-phase vibration, ie, vibration of inspiratory muscles during expiration, heightens the intensity of dyspnea [<a href="#rid47">47</a>]. It is important to note that the vibration used in these studies might also have stimulated pulmonary receptors.</p><p>While stimulation of chest wall receptors likely plays a role in the detection of changes in thoracic expansion, pulmonary receptors are sufficient to monitor lung volume. Patients with cervical spinal cord injury, for example, in whom information from chest wall receptors is interrupted before reaching the brain, can detect small changes in tidal volume and experience respiratory discomfort when tidal volumes are reduced [<a href="#rid48">48,49</a>].</p><p class="headingAnchor" id="H10"><span class="h1">MECHANICAL LOADING OF THE RESPIRATORY SYSTEM</span><span class="headingEndMark"> — </span>A wide variety of cardiopulmonary diseases are associated with an increased mechanical load due to changes in airways resistance (eg, asthma, chronic obstructive pulmonary disease [COPD]) or pulmonary or chest wall compliance (eg, idiopathic pulmonary fibrosis, kyphoscoliosis). To achieve a given tidal volume under these conditions, the brain must generate a greater neural output to the ventilatory muscles [<a href="#rid50">50</a>].</p><p>Outgoing motor commands to the ventilatory muscles probably are associated with a corollary discharge to the sensory cortex, which is perceived as a "sense of effort" [<a href="#rid51">51</a>]. The sense of effort appears to be a function of the ratio of the pressure generated by the ventilatory muscles on a given breath to the maximal pressure achievable by the muscles [<a href="#rid52">52</a>]. Thus, the sense of effort may increase because there is an obstruction to flow and the intrathoracic pressure generated on each breath is high, or because the pressure-generating capacity of the muscles is reduced, as is seen in the presence of muscle fatigue, myopathy, or hyperinflation.</p><p>Normal subjects maintaining a constant ventilatory target experience less effort but more dyspnea when hypercapnic than eucapnic [<a href="#rid18">18</a>], suggesting that ventilation arising from "automatic" or reflexive mechanisms (ie, stimulation of chemoreceptors by hypercapnia) results in a lesser sense of effort than voluntary increases in ventilation. While mechanical loading and the effort to breathe are common features of dyspnea in many disease states, they do not explain respiratory discomfort in all settings.</p><p class="headingAnchor" id="H11"><span class="h1">NEUROMECHANICAL DISSOCIATION</span><span class="headingEndMark"> — </span>Efferent neural impulses exit the brain and proceed to the ventilatory muscles, where they trigger contraction, generation of negative pressure within the thorax, and inspiratory air flow with expansion of the lungs and chest wall. If there is a mechanical load suddenly imposed on the respiratory system with no change in the neurologic command to the ventilatory muscles, the muscles will not shorten appropriately for the tension being generated, intrathoracic pressures will be less negative than normal, inspiratory flow will be reduced, and tidal volume will be diminished.</p><p>Although the exact means by which the body makes the comparison between what is expected under normal conditions for a given efferent message and the actual outcome of that message remains unclear, the mismatch between the two (termed "efferent-reafferent dissociation" [<a href="#rid53">53</a>] or "neuromechanical dissociation" [<a href="#rid54">54</a>]) appears to worsen the intensity of dyspnea. This mechanism may in part explain the dyspnea associated with experimentally constrained ventilation [<a href="#rid33">33,34</a>], hyperinflation in COPD [<a href="#rid35">35,54,55</a>], hyperinflation in asthma [<a href="#rid56">56</a>], and in some patients on mechanical ventilators [<a href="#rid36">36,57</a>], particularly those receiving low tidal volume ventilation as a strategy to avoid acute lung injury. It may also explain the amelioration of dyspnea with chest wall vibration [<a href="#rid44">44-46</a>] or a flow of air on the face [<a href="#rid28">28</a>].</p><p>In these last two examples, receptors in the chest wall and in the distribution of the trigeminal nerve are stimulated exogenously. It is believed that such stimulation, by conveying to the brain information that would indicate the respiratory system had achieved greater flows or volume displacement than actually had occurred, would lead to reduced discrepancy between the efferent neural command and the "apparent" mechanical response, thereby diminishing the intensity of dyspnea.</p><p>With the advent of low tidal volume ventilation for patients with acute respiratory distress syndrome [<a href="#rid58">58</a>], there is increasing concern about the dyspnea that may accompany this treatment strategy. The contribution of restricted tidal volume and associated dyspnea to the development of emotional problems, including posttraumatic stress disorder, in patients surviving acute respiratory failure has been postulated as a concern during the coronavirus disease 2019 (COVID-19) pandemic [<a href="#rid59">59</a>]. </p><p class="headingAnchor" id="H12"><span class="h1">IMPAIRED OXYGEN DELIVERY OR UTILIZATION</span><span class="headingEndMark"> — </span>Anemia and cardiovascular deconditioning are two common clinical conditions that are associated with exertional dyspnea and do not readily fit into the categories outlined above.</p><p class="headingAnchor" id="H13"><span class="h2">Anemia</span><span class="headingEndMark"> — </span>Patients with moderate to severe anemia typically experience breathing discomfort with light exercise despite the absence of a gas exchange abnormality or mechanical loading of the respiratory system. The response of the body to the reduced oxygen-carrying capacity of the blood is to increase cardiac output. This may necessitate an increase in left ventricular end-diastolic pressure with consequent increases in pulmonary venous pressures, the development of interstitial edema, and stimulation of C-fibers. However, tachycardia, rather than increased stroke volume, is often the first response of the cardiovascular system, and it is unclear to what extent intracardiac and pulmonary vascular pressures rise in this setting.</p><p>An alternative explanation is that the reduced delivery of oxygen to the metabolically active muscles may lead to the development of a localized metabolic acidosis and the stimulation of "ergoreceptors" or "metaboreceptors" in the peripheral muscles [<a href="#rid60">60,61</a>]. Another possibility is that the ventilatory muscles are impaired by inadequate oxygen delivery during exercise, which could lead to muscle fatigue under conditions of sustained hyperpnea.</p><p class="headingAnchor" id="H14"><span class="h2">Deconditioning</span><span class="headingEndMark"> — </span>An individual's fitness is determined by the ability of the cardiovascular system to deliver oxygenated blood to the muscles and by the capability of the muscles to utilize that oxygen via aerobic metabolism to engage in mechanical work. Exercise programs improve fitness by training the heart to generate a greater cardiac output and by inducing capillary growth and enzyme changes in skeletal muscle to improve the delivery of oxygen and efficiency of oxygen use. (See  <a class="medical medical_review" href="/d/html/1433.html" rel="external">"Exercise physiology"</a>.)</p><p>Many patients with chronic lung disease assume a sedentary lifestyle and become deconditioned; functional capabilities may be determined more by their level of fitness than by their underlying respiratory illness [<a href="#rid62">62</a>]. Dyspnea on exertion in these individuals may result primarily from reliance on anaerobic metabolism at low levels of exercise, development of a metabolic acidosis, and increased neural output from the respiratory centers. Whether the development of localized acidosis and stimulation of ergoreceptors also play a role in this situation remains uncertain. In addition, for some patients with chronic diseases that impair their functional capacity leading to a very limited lifestyle, normal increases in ventilation with exercise may be perceived as pathologic, ie, they become sensitized to dyspneic stimuli.</p><p class="headingAnchor" id="H15"><span class="h1">NEURAL ACTIVATION ASSOCIATED WITH BREATHING DISCOMFORT</span><span class="headingEndMark"> — </span>Investigators have begun to employ positron emission tomography and magnetic resonance imaging as tools to localize regions of the brain that are activated when breathing discomfort is induced experimentally. Acute hypercapnia [<a href="#rid63">63</a>], restriction of tidal volume [<a href="#rid64">64</a>], and imposition of external resistive loads [<a href="#rid65">65,66</a>] have all led to activation of areas within the limbic system and, to a lesser degree, within the brainstem. These areas of the brain also are likely to be involved in the perception of uncomfortable sensations such as pain and hunger. Whether future studies utilizing this technique will identify clearly delineated neural pathways for different types of dyspnea remains to be seen.</p><p class="headingAnchor" id="H21128149"><span class="h2">The affective dimension of dyspnea</span><span class="headingEndMark"> — </span>There is growing evidence that the emotional response to a stimulus that produces dyspnea varies and may be responsible, in part, for the different experiences and reports of the severity of dyspnea by patients [<a href="#rid15">15,67,68</a>]. Higher degrees of dyspnea-related fear in patients with chronic obstructive pulmonary disease (COPD) may predict salutary response to pulmonary rehabilitation programs, which emphasize reassurance that the sensation of dyspnea with a particular activity is not harmful [<a href="#rid69">69</a>]. For the same degree of sensory discomfort, air hunger results in greater fear and anxiety than increased work of breathing [<a href="#rid15">15</a>].</p><p class="headingAnchor" id="H3025273960"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118217.html" rel="external">"Society guideline links: Dyspnea"</a>.)</p><p class="headingAnchor" id="H16"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Descriptions of dyspnea</strong> – Breathing discomfort is a complex set of sensations which clinicians group under the term dyspnea. The physiologic mechanisms underlying these sensations are varied, and multiple mechanisms may be present in a given patient (<a class="graphic graphic_figure graphicRef69322" href="/d/graphic/69322.html" rel="external">figure 1</a>). (See <a class="local">'Descriptions of dyspnea'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common mechanisms of dyspnea</strong> – Most conditions that are associated with respiratory discomfort are characterized by increases in ventilation in response to derangements in ventilation-perfusion matching, increases in dead space, the presence of metabolic acidosis, or stimulation of pulmonary or chest wall receptors. (See <a class="local">'Increased output from the respiratory centers'</a> above.)</p><p></p><p class="bulletIndent1">While mechanical loading and the effort to breathe are common features of dyspnea in many disease states, they do not completely explain respiratory discomfort in all settings; stimulation of receptors throughout the respiratory system, changes in oxygen delivery to tissues, and arterial tensions of oxygen and carbon dioxide also contribute. (See <a class="local">'Increased output from the respiratory centers'</a> above and <a class="local">'Impaired oxygen delivery or utilization'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory system efferents</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Chemoreceptors</strong> – The peripheral chemoreceptors, located in the carotid bodies and aortic arch, sense changes in the partial pressure of oxygen in arterial blood and are also stimulated by acidosis and hypercapnia. The central chemoreceptors, located in the medulla, respond to changes in pH and arterial tension of carbon dioxide (PaCO<sub>2</sub>). (See <a class="local">'Chemoreceptors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mechanoreceptors</strong> – A variety of mechanoreceptors that assist the body in monitoring changes in pressure, flow, and volume in the respiratory system are located in the airways, lungs, and chest wall. Airway mechanoreceptors may be the primary source of the sensation of "chest tightness" associated with bronchoconstriction. (See <a class="local">'Stimulation of mechanoreceptors'</a> above.)</p><p></p><p class="bulletIndent2">A wide variety of cardiopulmonary diseases are associated with an increased mechanical load due to changes in airways resistance (eg, asthma, chronic obstructive pulmonary disease [COPD]) or pulmonary or chest wall compliance (eg, idiopathic pulmonary fibrosis, kyphoscoliosis). (See <a class="local">'Stimulation of mechanoreceptors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuromechanical dissociation</strong> – A mismatch between what is "expected" under normal conditions for a given efferent message to the respiratory muscles and the actual outcome of that message (eg, increased tidal volume, flow, and ventilation) may contribute to the sensation of dyspnea and is called "efferent-reafferent dissociation" or "neuromechanical dissociation." The exact means by which the body makes the comparison between the expected and actual outcome of a neural message to the respiratory muscles remains unclear. (See <a class="local">'Neuromechanical dissociation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multifactorial dyspnea</strong> – The sensation of dyspnea is often due to a combination of multiple factors. Individuals with COPD, for example, may experience breathlessness because of hypoxemia (increased neural input from peripheral chemoreceptors and output from the respiratory centers), increased airways resistance and hyperinflation (mechanical loading), and neuromechanical dissociation (associated with dynamic hyperinflation). In the presence of an acute respiratory infection or volume overload, stimulation of pulmonary receptors may also play a role.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J 1988; 9:1215.</a></li><li class="breakAll">Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease (COPD). http://www.cdc.gov/copd/data.htm (Accessed on April 21, 2016).</li><li class="breakAll">Centers for Disease Control and Prevention. Asthma. http://www.cdc.gov/nchs/fastats/asthma.htm (Accessed on April 21, 2016).</li><li><a class="nounderline abstract_t">Stevens JP, Dechen T, Schwartzstein R, et al. Prevalence of Dyspnea Among Hospitalized Patients at the Time of Admission. J Pain Symptom Manage 2018; 56:15.</a></li><li><a class="nounderline abstract_t">Stevens JP, Dechen T, Schwartzstein RM, et al. Association of dyspnoea, mortality and resource use in hospitalised patients. Eur Respir J 2021; 58.</a></li><li><a class="nounderline abstract_t">Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990; 142:1009.</a></li><li><a class="nounderline abstract_t">Elliott MW, Adams L, Cockcroft A, et al. The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease. Am Rev Respir Dis 1991; 144:826.</a></li><li><a class="nounderline abstract_t">Mahler DA, Harver A, Lentine T, et al. Descriptors of breathlessness in cardiorespiratory diseases. Am J Respir Crit Care Med 1996; 154:1357.</a></li><li class="breakAll">Schwartzstein RM. The language of dyspnea. In: Dyspnea: Mechanisms, measurement, and management, Mahler DA, O'Donnell DE (Eds), Marcel Dekker, New York 2005. p.115.</li><li><a class="nounderline abstract_t">Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012; 185:435.</a></li><li><a class="nounderline abstract_t">Scano G, Ambrosino N. Pathophysiology of dyspnea. Lung 2002; 180:131.</a></li><li><a class="nounderline abstract_t">Jensen D, Webb KA, Davies GA, O'Donnell DE. Mechanisms of activity-related breathlessness in healthy human pregnancy. Eur J Appl Physiol 2009; 106:253.</a></li><li><a class="nounderline abstract_t">Haugdahl HS, Storli SL, Meland B, et al. Underestimation of Patient Breathlessness by Nurses and Physicians during a Spontaneous Breathing Trial. Am J Respir Crit Care Med 2015; 192:1440.</a></li><li><a class="nounderline abstract_t">Banzett RB, Schwartzstein RM. Dyspnea: Don't Just Look, Ask! Am J Respir Crit Care Med 2015; 192:1404.</a></li><li><a class="nounderline abstract_t">Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort. Am J Respir Crit Care Med 2008; 177:1384.</a></li><li><a class="nounderline abstract_t">Banzett RB, Lansing RW, Reid MB, et al. 'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics. Respir Physiol 1989; 76:53.</a></li><li><a class="nounderline abstract_t">Banzett RB, Lansing RW, Brown R, et al. 'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans. Respir Physiol 1990; 81:1.</a></li><li><a class="nounderline abstract_t">Demediuk BH, Manning H, Lilly J, et al. Dissociation between dyspnea and respiratory effort. Am Rev Respir Dis 1992; 146:1222.</a></li><li class="breakAll">Banzett RB, Lansing RW. Respiratory sensations arising from pulmonary and chemoreceptor afferents. In: Respiratory Sensation, Adams L, Guz A (Eds), Marcel Dekker Inc, New York 1996. p.155.</li><li><a class="nounderline abstract_t">Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, et al. An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med 2010; 181:626.</a></li><li><a class="nounderline abstract_t">Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci (Lond) 1988; 74:531.</a></li><li><a class="nounderline abstract_t">Lane R, Cockcroft A, Adams L, Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin Sci (Lond) 1987; 72:693.</a></li><li><a class="nounderline abstract_t">Adams L, Lane R, Shea SA, et al. Breathlessness during different forms of ventilatory stimulation: a study of mechanisms in normal subjects and respiratory patients. Clin Sci (Lond) 1985; 69:663.</a></li><li><a class="nounderline abstract_t">Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit Care Med 2020; 202:356.</a></li><li><a class="nounderline abstract_t">Taguchi O, Kikuchi Y, Hida W, et al. Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea. J Appl Physiol (1985) 1991; 71:2183.</a></li><li><a class="nounderline abstract_t">Moy ML, Woodrow Weiss J, Sparrow D, et al. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000; 162:451.</a></li><li><a class="nounderline abstract_t">McBride B, Whitelaw WA. A physiological stimulus to upper airway receptors in humans. J Appl Physiol Respir Environ Exerc Physiol 1981; 51:1189.</a></li><li><a class="nounderline abstract_t">Schwartzstein RM, Lahive K, Pope A, et al. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis 1987; 136:58.</a></li><li><a class="nounderline abstract_t">Spence DP, Graham DR, Ahmed J, et al. Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease? Chest 1993; 103:693.</a></li><li><a class="nounderline abstract_t">Simon PM, Basner RC, Weinberger SE, et al. Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects. Am Rev Respir Dis 1991; 144:419.</a></li><li><a class="nounderline abstract_t">Ruangsomboon O, Dorongthom T, Chakorn T, et al. High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Relieving Dyspnea in Emergency Palliative Patients With Do-Not-Intubate Status: A Randomized Crossover Study. Ann Emerg Med 2020; 75:615.</a></li><li><a class="nounderline abstract_t">FOWLER WS. Breaking point of breath-holding. J Appl Physiol 1954; 6:539.</a></li><li><a class="nounderline abstract_t">Chonan T, Mulholland MB, Cherniack NS, Altose MD. Effects of voluntary constraining of thoracic displacement during hypercapnia. J Appl Physiol (1985) 1987; 63:1822.</a></li><li><a class="nounderline abstract_t">Schwartzstein RM, Simon PM, Weiss JW, et al. Breathlessness induced by dissociation between ventilation and chemical drive. Am Rev Respir Dis 1989; 139:1231.</a></li><li><a class="nounderline abstract_t">O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997; 155:109.</a></li><li><a class="nounderline abstract_t">Schmidt M, Demoule A, Polito A, et al. Dyspnea in mechanically ventilated critically ill patients. Crit Care Med 2011; 39:2059.</a></li><li><a class="nounderline abstract_t">Nishino T, Ide T, Sudo T, Sato J. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000; 161:1963.</a></li><li><a class="nounderline abstract_t">Moosavi SH, Binks AP, Lansing RW, et al. Effect of inhaled furosemide on air hunger induced in healthy humans. Respir Physiol Neurobiol 2007; 156:1.</a></li><li><a class="nounderline abstract_t">Jensen D, Amjadi K, Harris-McAllister V, et al. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD. Thorax 2008; 63:606.</a></li><li><a class="nounderline abstract_t">Banzett RB, Schwartzstein RM, Lansing RW, O'Donnell CR. Aerosol furosemide for dyspnea: High-dose controlled delivery does not improve effectiveness. Respir Physiol Neurobiol 2018; 247:24.</a></li><li><a class="nounderline abstract_t">Morélot-Panzini C, O'Donnell CR, Lansing RW, et al. Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness. Respir Physiol Neurobiol 2018; 247:146.</a></li><li><a class="nounderline abstract_t">Simon PM, Schwartzstein RM, Weiss JW, et al. Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis 1989; 140:1021.</a></li><li><a class="nounderline abstract_t">Manning HL, Schwartzstein RM. Pathophysiology of dyspnea. N Engl J Med 1995; 333:1547.</a></li><li><a class="nounderline abstract_t">Manning HL, Basner R, Ringler J, et al. Effect of chest wall vibration on breathlessness in normal subjects. J Appl Physiol (1985) 1991; 71:175.</a></li><li><a class="nounderline abstract_t">Sibuya M, Yamada M, Kanamaru A, et al. Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease. Am J Respir Crit Care Med 1994; 149:1235.</a></li><li><a class="nounderline abstract_t">Cristiano LM, Schwartzstein RM. Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155:1552.</a></li><li><a class="nounderline abstract_t">Homma I, Obata T, Sibuya M, Uchida M. Gate mechanism in breathlessness caused by chest wall vibration in humans. J Appl Physiol Respir Environ Exerc Physiol 1984; 56:8.</a></li><li><a class="nounderline abstract_t">Banzett RB, Lansing RW, Brown R. High-level quadriplegics perceive lung volume change. J Appl Physiol (1985) 1987; 62:567.</a></li><li><a class="nounderline abstract_t">Manning HL, Shea SA, Schwartzstein RM, et al. Reduced tidal volume increases 'air hunger' at fixed PCO2 in ventilated quadriplegics. Respir Physiol 1992; 90:19.</a></li><li><a class="nounderline abstract_t">Mendonca CT, Schaeffer MR, Riley P, Jensen D. Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive. J Appl Physiol (1985) 2014; 116:570.</a></li><li class="breakAll">McCloskey DI. Corollary discharges: Motor commands and perception. In: Handbook of Physiology, Section I, The Nervous System, Brookahrt JM, Mountcastle VB (Eds), American Physiological Society, Bethesda 1981. Vol II, p.1415.</li><li><a class="nounderline abstract_t">Killian KJ, Gandevia SC, Summers E, Campbell EJ. Effect of increased lung volume on perception of breathlessness, effort, and tension. J Appl Physiol Respir Environ Exerc Physiol 1984; 57:686.</a></li><li><a class="nounderline abstract_t">Schwartzstein RM, Manning HL, Weiss JW, Weinberger SE. Dyspnea: a sensory experience. Lung 1990; 168:185.</a></li><li><a class="nounderline abstract_t">O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148:1351.</a></li><li><a class="nounderline abstract_t">O'Donnell DE, Banzett RB, Carrieri-Kohlman V, et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4:145.</a></li><li><a class="nounderline abstract_t">Lougheed MD, Fisher T, O'Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest 2006; 130:1072.</a></li><li><a class="nounderline abstract_t">Manning HL, Molinary EJ, Leiter JC. Effect of inspiratory flow rate on respiratory sensation and pattern of breathing. Am J Respir Crit Care Med 1995; 151:751.</a></li><li><a class="nounderline abstract_t">Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med 2007; 175:160.</a></li><li><a class="nounderline abstract_t">Worsham CM, Banzett RB, Schwartzstein RM. Air Hunger and Psychological Trauma in Ventilated Patients with COVID-19. An Urgent Problem. Ann Am Thorac Soc 2020; 17:926.</a></li><li><a class="nounderline abstract_t">Clark AL, Piepoli M, Coats AJ. Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors. Eur J Clin Invest 1995; 25:299.</a></li><li><a class="nounderline abstract_t">Clark A, Volterrani M, Swan JW, et al. Leg blood flow, metabolism and exercise capacity in chronic stable heart failure. Int J Cardiol 1996; 55:127.</a></li><li><a class="nounderline abstract_t">Killian KJ, Leblanc P, Martin DH, et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146:935.</a></li><li><a class="nounderline abstract_t">Corfield DR, Fink GR, Ramsay SC, et al. Evidence for limbic system activation during CO2-stimulated breathing in man. J Physiol 1995; 488 ( Pt 1):77.</a></li><li><a class="nounderline abstract_t">Banzett RB, Mulnier HE, Murphy K, et al. Breathlessness in humans activates insular cortex. Neuroreport 2000; 11:2117.</a></li><li><a class="nounderline abstract_t">Peiffer C, Poline JB, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163:951.</a></li><li><a class="nounderline abstract_t">von Leupoldt A, Sommer T, Kegat S, et al. Down-regulation of insular cortex responses to dyspnea and pain in asthma. Am J Respir Crit Care Med 2009; 180:232.</a></li><li><a class="nounderline abstract_t">Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009; 167:53.</a></li><li><a class="nounderline abstract_t">Meek PM, Banzett R, Parshall MB, et al. Reliability and validity of the multidimensional dyspnea profile. Chest 2012; 141:1546.</a></li><li><a class="nounderline abstract_t">Janssens T, De Peuter S, Stans L, et al. Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011; 140:618.</a></li></ol></div><div id="topicVersionRevision">Topic 1427 Version 16.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3234413" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Breathlessness, lung function and the risk of heart attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3234413" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Breathlessness, lung function and the risk of heart attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3234413" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Breathlessness, lung function and the risk of heart attack.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29476798" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of Dyspnea Among Hospitalized Patients at the Time of Admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33653806" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Association of dyspnoea, mortality and resource use in hospitalised patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2240820" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Distinguishable types of dyspnea in patients with shortness of breath.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1928956" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The language of breathlessness. Use of verbal descriptors by patients with cardiopulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8912748" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Descriptors of breathlessness in cardiorespiratory diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8912748" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Descriptors of breathlessness in cardiorespiratory diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22336677" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12177728" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pathophysiology of dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19255773" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mechanisms of activity-related breathlessness in healthy human pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26669474" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Underestimation of Patient Breathlessness by Nurses and Physicians during a Spontaneous Breathing Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26669467" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Dyspnea: Don't Just Look, Ask!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18369200" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work/effort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2499025" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : 'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2120757" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : 'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1443874" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Dissociation between dyspnea and respiratory effort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1443874" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Dissociation between dyspnea and respiratory effort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20208042" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : An official ATS clinical policy statement: Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3370920" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3595075" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3933895" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Breathlessness during different forms of ventilatory stimulation: a study of mechanisms in normal subjects and respiratory patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32539537" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1778911" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10934069" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Quality of dyspnea in bronchoconstriction differs from external resistive loads.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7298459" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A physiological stimulus to upper airway receptors in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3605841" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cold facial stimulation reduces breathlessness induced in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8449053" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Does cold air affect exercise capacity and dyspnea in stable chronic obstructive pulmonary disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1859070" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31864728" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : High-Flow Nasal Cannula Versus Conventional Oxygen Therapy in Relieving Dyspnea in Emergency Palliative Patients With Do-Not-Intubate Status: A Randomized Crossover Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13152037" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Breaking point of breath-holding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3121574" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effects of voluntary constraining of thoracic displacement during hypercapnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2523682" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Breathlessness induced by dissociation between ventilation and chemical drive.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9001298" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21572329" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Dyspnea in mechanically ventilated critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10852774" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16935035" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Effect of inhaled furosemide on air hunger induced in healthy humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18250181" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28843675" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Aerosol furosemide for dyspnea: High-dose controlled delivery does not improve effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29031573" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Aerosol furosemide for dyspnea: Controlled delivery does not improve effectiveness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2508520" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Distinguishable sensations of breathlessness induced in normal volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7477171" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pathophysiology of dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1917740" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Effect of chest wall vibration on breathlessness in normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8173764" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Effect of chest wall vibration on dyspnea in patients with chronic respiratory disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9154856" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Effect of chest wall vibration on dyspnea during hypercapnia and exercise in chronic obstructive pulmonary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6693337" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Gate mechanism in breathlessness caused by chest wall vibration in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3558216" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : High-level quadriplegics perceive lung volume change.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1455095" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Reduced tidal volume increases 'air hunger' at fixed PCO2 in ventilated quadriplegics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356524" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24356524" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6490457" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Effect of increased lung volume on perception of breathlessness, effort, and tension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2122135" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Dyspnea: a sensory experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8239175" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17494725" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17035440" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7881666" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Effect of inspiratory flow rate on respiratory sensation and pattern of breathing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17038660" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32501114" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Air Hunger and Psychological Trauma in Ventilated Patients with COVID-19. An Urgent Problem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7628515" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8842781" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Leg blood flow, metabolism and exercise capacity in chronic stable heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1416421" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8568667" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Evidence for limbic system activation during CO2-stimulated breathing in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10923655" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Breathlessness in humans activates insular cortex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11282772" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Neural substrates for the perception of acutely induced dyspnea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19483110" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Down-regulation of insular cortex responses to dyspnea and pain in asthma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18706531" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The multiple dimensions of dyspnea: review and hypotheses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22267681" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Reliability and validity of the multidimensional dyspnea profile.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21493698" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Dyspnea perception in COPD: association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
